cross-resistance in anti-androgen therapy
Interviews and expert commentary tagged “cross-resistance in anti-androgen therapy” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Oncology
Responses to enzalutamide after prior abiraterone therapy in men with castration-resistant metastatic prostate cancer
SAN FRANCISCO— Four out of ten patients whose metastatic castration resistant prostate cancer had already been treated with abiraterone responded to further ‘new generation’ androgen depri
11 February 2014
0:00